Takeda Pharmaceutical (TAK) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.15
0.08
0.32
0.55

Details

Expected EPS
-0.15124647
Actual EPS
-0.09799688
Surprise EPS
0.05
Surprise Percent
+35.21%

Description

Takeda Pharmaceutical (TAK) has reported earnings of -0.09799688 per share for Q2 2026.

0 Comments

Share your thoughts